Skip to main content
Livermore
Livermore
ZHEN

CG Oncology, Inc.

CGON
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001991792

In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding CG Oncology, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CGON: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1631176+14
Shares75.9M8.93K77.6M+1.74M (+2.3%)
Value$1.97B$232.2K$3.13B+$1.15B (+58.5%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held CG Oncology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CGON in Q3 2025
InstitutionSharesValue% of portfolio
Clearbridge Investments, LLC613,852$24.7M0.02%
Vestal Point Capital, LP175,000$7.05M0.32%
PFM Health Sciences, LP157,874$6.36M0.54%
Nantahala Capital Management, LLC109,449$4.41M0.27%
First Trust Advisors LP75,539$3.04M0.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main63,720$2.57M0.00%
StemPoint Capital LP63,019$2.54M0.51%
Marshall Wace, LLP56,377$2.27M0.00%
Cubist Systematic Strategies, LLC43,067$1.73M0.02%
ExodusPoint Capital Management, LP20,850$839.8K0.01%
Quest Partners LLC13,600$547.8K0.04%
Brevan Howard Capital Management LP13,224$532.7K0.01%
Natixis12,437$501.0K0.00%
Voleon Capital Management LP10,172$409.7K0.01%
State Board of Administration of Florida Retirement System9,185$370.0K0.00%
Creative Planning7,055$284.2K0.00%
Prudential Financial Inc6,995$281.8K0.00%
Mariner, LLC6,932$279.2K0.00%
Bridgefront Capital, LLC6,132$247.0K0.07%
CIBC Bancorp USA Inc.5,957$239.9K0.00%
LPL Financial LLC5,650$227.6K0.00%
Verition Fund Management LLC5,487$221.0K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH5,227$210.5K0.00%
Wealth Enhancement Advisory Services, LLC5,485$208.4K0.00%
Strengthening Families & Communities, LLC1,000$40.3K0.01%
Point72 Europe (London) LLP626$25.2K0.00%
Optiver Holding B.V.444$17.9K0.00%
Private Trust Co NA71$2.86K0.00%
Global Retirement Partners, LLC33$1.33K0.00%
Rise Advisors, LLC19$7650.00%
Farther Finance Advisors, LLC10$4030.00%
Advisory Services Network, LLC5$2010.00%
Jones Financial Companies LLLP1$380.00%

Sold out (19)

Institutions that held CG Oncology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CGON in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Frazier Life Sciences Management, L.P.770,000$20.0M
Alyeska Investment Group, L.P.150,000$3.90M
Susquehanna International Group, LLP93,793$2.44M
Canada Pension Plan Investment Board86,600$2.25M
Nomura Holdings Inc46,239$1.20M
Renaissance Technologies LLC46,100$1.20M
Tejara Capital Ltd36,291$943.6K
Twinbeech Capital LP26,979$701.5K
UBS Oconnor LLC26,000$676.0K
Neo Ivy Capital Management15,758$409.7K
Los Angeles Capital Management LLC11,197$291.1K
Capstone Investment Advisors, LLC10,795$280.7K
Winton Group Ltd8,669$225.4K
Man Group plc8,619$224.1K
Aigen Investment Management, LP8,556$222.5K
Group One Trading, L.P.3,985$103.6K
Exchange Traded Concepts, LLC912$23.7K
Caitong International Asset Management Co., Ltd126$3.28K
Skopos Labs, Inc.23$598

Not filed for Q3 2025 yet (1)

Institutions that held CG Oncology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGON in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
E Fund Management Co., Ltd.8,932$232.2K